Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
618.00
-18.00 (-2.83%)
At close: Jan 30, 2026
Kyung Nam Pharm Revenue
Kyung Nam Pharm had revenue of 13.09B KRW in the quarter ending March 31, 2025, a decrease of -26.03%. This brings the company's revenue in the last twelve months to 56.18B, down -9.99% year-over-year. In the year 2024, Kyung Nam Pharm had annual revenue of 60.79B with 2.51% growth.
Revenue (ttm)
56.18B
Revenue Growth
-9.99%
P/S Ratio
0.95
Revenue / Employee
231.21M
Employees
243
Market Cap
53.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60.79B | 1.49B | 2.51% |
| Dec 31, 2023 | 59.30B | 303.06M | 0.51% |
| Dec 31, 2022 | 59.00B | -5.62B | -8.70% |
| Dec 31, 2021 | 64.62B | -6.31B | -8.89% |
| Dec 31, 2020 | 70.93B | 26.13B | 58.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmax Nbt | 293.75B |
| Korea Arlico Pharm | 205.21B |
| RP Bio | 134.21B |
| Jin Yang Pharmaceutical | 117.19B |
| GeneBioTech Co. ,Ltd | 92.28B |
| Sinil Pharmaceutical | 80.97B |
| Korean Drug | 62.21B |
| Seoul Pharma | 52.43B |